CALL US

News

Applied Clinical Trials Features Article on 21st Century Cures Act

January 26th, 2017

Applied Clinical Trials recently featured an article written by Michele Russell-Einhorn, JD, Vice President of Human Research Protection Services and Institutional Official at Schulman IRB, that outlines the provisions of the 21st Century Cures Act that was passed in early December. Russell-Einhorn explains how these changes will successfully preserve conscionable safeguards of safety and efficacy, eliminate undue development hurdles, and increase patient access to breakthrough treatments.

Read the full story here.

BACK TO NEWS